The effects of sulfasalazine treatment on enthesal abnormalities of inflammatory rheumatic diseases.

Author: Duyur CakitBurcu, ErdemHatice Rana, GencHakan, KacarMahmut, NacirBaris, SaracogluMeryem

Paper Details 
Original Abstract of the Article :
The aim of this study was to evaluate the effects of a 1-year course of sulfasalazine monotherapy on enthesal abnormalities of inflammatory rheumatic diseases (IRDs) using ultrasonography. Thirty-six patients with IRD including 20 patients with rheumatoid arthritis (RA) and 16 patients with ankylosi...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1007/s10067-006-0460-6

データ提供:米国国立医学図書館(NLM)

Sulfasalazine's Effects on Enthesal Abnormalities in Inflammatory Rheumatic Diseases

The world of inflammatory rheumatic diseases (IRDs) is like a vast, arid landscape, where the body's own immune system turns against its own tissues, causing pain and inflammation. This study focuses on the impact of sulfasalazine, a commonly used medication for IRDs, on enthesal abnormalities, the points where ligaments and tendons attach to bones.

The researchers used ultrasonography to assess enthesal structures in patients with IRDs, comparing their findings to healthy controls. While sulfasalazine demonstrated improvements in clinical and laboratory markers of inflammation, it did not show significant improvement in enthesal abnormalities, suggesting that the treatment may not directly target this aspect of the disease.

This study provides valuable insights into the complexities of IRDs, highlighting the need for further research to develop more effective treatments that address the full range of symptoms, including enthesal abnormalities.

A Deeper Understanding of IRDs

The study reveals that enthesal abnormalities are a significant feature of IRDs, and while sulfasalazine can improve overall inflammation, its effectiveness in addressing enthesal issues is limited. This underscores the need for targeted therapies to address specific aspects of IRD pathology.

Living with IRDs: Navigating the Landscape of Symptoms

This research emphasizes the importance of understanding the multifaceted nature of IRDs and seeking comprehensive treatment plans that address both systemic inflammation and specific symptoms like enthesal abnormalities.

Dr. Camel's Conclusion

The journey through the desert of inflammatory rheumatic diseases can be challenging. This research sheds light on the complexities of IRDs, emphasizing the need for a multi-pronged approach to treatment that addresses both systemic inflammation and specific symptoms. It serves as a valuable reminder to stay informed and actively participate in managing one's health journey.

Date :
  1. Date Completed 2007-08-16
  2. Date Revised 2022-07-16
Further Info :

Pubmed ID

17086383

DOI: Digital Object Identifier

10.1007/s10067-006-0460-6

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.